drugset / Trial / NCT00280696
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures
RandomizedParallel-groupTriple-blindTreatment
Summary
A double-blind, randomized, multicenter, placebo controlled 5 parallel groups, confirmatory trial to evaluated the efficacy and safety of levetiracetam used as adjunctive treatment in patients from 16 to 65 years with epilepsy suffering from partial onset seizures.
Timeline
- Start
- 2005-11
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 500 mg | Oral |
| Subject | Levetiracetam | Other / unclassified | 1000 mg | Oral |
| Subject | Levetiracetam | Other / unclassified | 2000 mg | Oral |
| Subject | Levetiracetam | Other / unclassified | 3000 mg | Oral |